McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) is the only Texas site for a Phase III clinical trial to evaluate the safety and efficacy of an investigational medication called CM-AT to treat the symptoms of autism in children ages 3 to 8. The principal investigator of the Texas site for the Blüm Study is Deborah A. Pearson, Ph.D., professor in the Department of Psychiatry and Behavioral Sciences at […]
